HEALTH● LOWSep 30 · Sep 30, 2026, 1:28 PM
Merck succeeds in mid-stage trial for skin disease drug
Seeking Alpha Tech · global
Merck has successfully completed a mid-stage trial for a new drug designed to treat skin disease, which could lead to new treatment options for patients.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH49m agoKFF: Individual health insurance enrollment fell 18 percent in JuneThe HillHEALTH1h agoPaxton suing Gerber and Nestlé over alleged arsenic and lead in baby foodThe HillHEALTH1h agoKenya confirms second Ebola case as contact develops symptoms in quarantinePremium TimesHEALTH1h agoTrump’s CDC sending disease detective to Pennsylvania to help fight worst measles outbreak in 35 yearsThe Independent World